Yung-yao Lin

4 Newark Street
London, ENG E12AT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Engineered human myogenic cells in hydrogels generate innervated vascularized myofibers within dystrophic mouse muscle on long-term engraftment.

Engineered human myogenic cells in hydrogels generate innervated vascularized myofibers within dystrophic mouse muscle on long-term engraftment.

Journal: Cell reports. Medicine

Published: November 10, 2023

3D Compartmentalised Human Pluripotent Stem Cell-derived Neuromuscular Co-cultures.

3D Compartmentalised Human Pluripotent Stem Cell-derived Neuromuscular Co-cultures.

Journal: Bio-protocol

Published: August 25, 2022

CRISPR-mediated correction of skeletal muscle Ca2+ handling in a novel DMD patient-derived pluripotent stem cell model.

CRISPR-mediated correction of skeletal muscle Ca2+ handling in a novel DMD patient-derived pluripotent stem cell model.

Journal: Neuromuscular disorders : NMD

Published: June 09, 2022

Optogenetic modeling of human neuromuscular circuits in Duchenne muscular dystrophy with CRISPR and pharmacological corrections.

Optogenetic modeling of human neuromuscular circuits in Duchenne muscular dystrophy with CRISPR and pharmacological corrections.

Journal: Science advances

Published: September 13, 2021

Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy.

Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy.

Journal: Journal of cachexia, sarcopenia and muscle

Published: May 07, 2021

Comparative epigenetic analysis of tumour initiating cells and syngeneic EPSC-derived neural stem cells in glioblastoma.

Comparative epigenetic analysis of tumour initiating cells and syngeneic EPSC-derived neural stem cells in glioblastoma.

Journal: Nature communications

Published: March 02, 2021

A new patient-derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of α-dystroglycan.

A new patient-derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of α-dystroglycan.

Journal: EMBO reports

Published: March 04, 2019

The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition.

The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition.

Journal: eLife

Published: January 16, 2016

Missense mutations in β-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker-Warburg syndrome.

Missense mutations in β-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker-Warburg syndrome.

Journal: Human molecular genetics

Published: January 30, 2013

Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan.

Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan.

Journal: American journal of human genetics

Published: August 30, 2012

Muscle diseases in the zebrafish.

Muscle diseases in the zebrafish.

Journal: Neuromuscular disorders : NMD

Published: February 21, 2012

Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycan.

Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycan.

Journal: Nature genetics

Published: November 07, 2011

Showing 1-12 of 13

Last Updated: 09/26/2026